We recently described an alternative surrogate actiation marker approach, relying on concurrent downregulation of surface CD8α and upregulation of CD11a (α-chain of LFA-1) on effector and memory antigen-specific CD8 T cells responding to bacterial and viral-infections in mice [18]. This evidence concerns the gene CD8A and viral infectious disease.